Document is current
Any future updates will be listed below
-
Authors
Parker, Amelia L. http://orcid.org/0000-0002-3142-8937
Bowman, Elise
Zingone, Adriana
Ryan, Brid M.
Cooper, Wendy A.
Kohonen-Corish, Maija
Harris, Curtis C.
Cox, Thomas R.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council
Cancer Council NSW (RG19-01)
Susan G. Komen
Cancer Institute NSW
National Breast Cancer Foundation
Lung Foundation Australia
- License Information
-
More Information
Article History
Received: 21 April 2022
Accepted: 14 October 2022
First Online: 21 November 2022
Declarations
:
: Publicly available data was obtained as described (Table InternalRef removed) and analyzed in accordance with the respective guidelines of each platform. NSCLC tumor and non-tumor biospecimens from the NCI-MD cohort were collected according to approved procedures as described previously [CitationRef removed] (National Cancer Institute, USA, IRB OH98-C-N027). Written informed consent was received prior to participation in these studies. This research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: Brid M. Ryan had no competing interests while involved with this research and is now a paid employee of Mina Therapeutics. The remaining authors declare that they have no competing interests.
